Basic Information
I, Chen Lihua, male, born in October 1954, of Chinese nationality, with no permanent residency abroad, hold a master's degree. From July 1982 to July 1983, I served as a teaching assistant at Anhui University, and from July 1986 to February 1993, I was a lecturer and associate professor at Nanjing University. From March 1993 to August 1993, I was an associate researcher at the Shenzhen Legal Research Institute. Since September 1993, I have held positions as an associate professor, professor, and doctoral supervisor at Suzhou University, retiring in October 2019. I currently serve as an independent director at Wuxi Chemical Equipment Co., Ltd. and Nanjing Jinling Hotel Co., Ltd., and have been an independent director of the company since September 2022. During the reporting period, my position met the independence requirements stipulated in Article 6 of the "Management Measures for Independent Directors of Listed Companies," with no circumstances affecting my independence.
2025 Performance Overview
- Attendance at Board Meetings In 2025, the company held 12 board meetings, and I attended all 12 meetings on time, with no instances of proxy attendance or absence. I carefully reviewed all proposals and actively participated in discussions, providing independent voting opinions based on my professional capabilities and experience. My attendance record for board meetings in 2025 is as follows:
| Total Meetings Required | In-Person Attendance (On-site/Remote) | Proxy Attendance | Absences | Consecutive Absences |
|---|---|---|---|---|
| 12 | 12 | 0 | 0 | No |
In 2025, I voted in favor of all proposals at the board meetings.
-
Attendance at Shareholder Meetings In 2025, the company held 1 annual shareholder meeting and 5 temporary shareholder meetings, all of which I attended in person, with no instances of consecutive absences exceeding two meetings.
-
Attendance at Specialized Committee Meetings In 2025, as the chairman of the company's nomination committee, I convened and held 3 nomination committee meetings, carefully reviewing and voting on matters related to the election of the fourth board of directors and senior management, as well as the role allocation of directors after the company's initial public offering of H shares on the Hong Kong Stock Exchange. I continuously monitored and supervised the qualifications and performance of the company's directors and senior management, ensuring compliance with regulations and promoting the company's sustainable development and core team building. As a member of the company's audit committee, I participated in 8 meetings, where I, along with other committee members, carefully reviewed and voted on relevant company matters.
-
Attendance at Independent Director Specialized Meetings In 2025, I was required to attend 4 specialized meetings for independent directors, and I attended all 4 meetings with no absences.
-
Exercise of Independent Director Powers In 2025, I diligently fulfilled my responsibilities as an independent director in accordance with the "Independent Director Work System" and "Independent Director Specialized Meeting Work System." The details of the meetings and proposals reviewed are as follows: